Ardevora Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-615,538
Closed -$54.3M 135
2021
Q1
$54.3M Buy
615,538
+64,701
+12% +$6.01M 0.81% 65
2020
Q4
$52.7M Sell
550,837
-22,700
-4% -$2.34M 0.81% 88
2020
Q3
$65.1M Sell
573,537
-14,500
-2% -$1.52M 1.19% 5
2020
Q2
$58.2M Sell
588,037
-83,999
-12% -$6.7M 1.14% 2
2020
Q1
$43.2M Sell
672,036
-203,300
-23% -$14.2M 1.15% 20
2019
Q4
$52.2M Buy
875,336
+174,500
+25% +$10.8M 1.17% 39
2019
Q3
$41.3M Buy
700,836
+86,200
+14% +$5.5M 1.15% 38
2019
Q2
$39.7M Sell
614,636
-64,900
-10% -$4.19M 0.97% 56
2019
Q1
$43.2M Sell
679,536
-420,300
-38% -$22.1M 1.13% 3
2018
Q4
$41.8M Buy
1,099,836
+236,440
+27% +$8.35M 1.25% 1
2018
Q3
$37M Buy
+863,396
New +$30.2M 1.03% 7

Other funds holding TNDM

Ardevora Asset Management's TNDM Position: Q2 2021 in Review

Ardevora Asset Management sold out of Tandem Diabetes Care (TNDM) in Q2 2021, closing a stake of 615,538 shares — an estimated $54.3M sold.

Ardevora Asset Management first reported a position in TNDM in Q3 2018 and held it in 11 quarters. The position peaked at $65.1M in Q3 2020. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2021.

  • Ardevora Asset Management reported no remaining Tandem Diabetes Care position as of Q2 2021 after selling out during the quarter.
  • Ardevora Asset Management sold 615,538 Tandem Diabetes Care shares in Q2 2021, an estimated $54.3M.
  • Ardevora Asset Management first reported a position in Tandem Diabetes Care in Q3 2018 and held it in 11 quarters.
  • Ardevora Asset Management's Tandem Diabetes Care position peaked at $65.1M in Q3 2020.
  • 303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2021.

Based on Ardevora Asset Management's 13F filing for Q2 2021, filed 22 Jul 2021.